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Estimating the incidence of colorectal cancer 
in Sub–Saharan Africa: A systematic analysis
Background Nearly two–thirds of annual mortality worldwide is at-
tributable to non–communicable diseases (NCDs), with 70% esti-
mated to occur in low– and middle–income countries (LMIC). 
Colorectal cancer (CRC) accounts for over 600 000 deaths annually, 
but data concerning cancer rates in LMIC is very poor. This study 
analyses the data available to produce an estimate of the incidence 
of colorectal cancer in Sub–Saharan Africa (SSA).
Methods Data for this analysis came from two main sources: a sys-
tematic search of Medline, EMBASE and Global Health which found 
15 published data sets, and an additional 42 unpublished data sets 
which were sourced from the IARC and individual cancer registries. 
Data for case rates by age and sex, as well as population denomina-
tors were extracted and analysed to produce an estimate of incidence.
Results: The crude incidence of CRC in SSA for both sexes was found 
to be 4.04 per 100 000 population (4.38 for men and 3.69 for wom-
en). Incidence increased with age with the highest rates in Southern 
Africa, particularly in South Africa. The rates of CRC in SSA were 
much lower than those reported for high–income countries.
Conclusion Few health services in SSA are equipped to provide 
timely diagnosis and treatment of cancer in SSA. In addition, data 
collection systems are weak, meaning that the available statistics may 
underestimate the burden of disease. In order to improve health care 
services it is vital that accurate measurements of disease burden are 
available to policy makers.
In 2008 cancer was the leading cause of mortality worldwide, responsible 
for the deaths of an estimated 7.6 million people [1]. Colorectal cancer 
(CRC) accounted for over 600 000 of those deaths, with 70% occurring 
in low– and middle–income countries [1,2]. With the emergence of non–
communicable diseases (NCD) in countries where traditionally the biggest 
problem were infections, it is estimated that, by 2030, cancer will become 
the cause of over 13 million deaths a year [3]. While rates of infectious 
diseases typically decrease with the economic growth of a country, rates 
of NCD do not appear to decrease until high levels of education and lit-
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the published literature (found through systematic review) 
and unpublished data on cancer registries to assess the bur-
den of CRC in SSA. We also aimed to explore the quality 
and availability of data and to make suggestions for re-
search and public health policy priorities to improve con-
trol of CRC in SSA.
METHODS
The data in this review came from cancer registries, and 
were identified through two main sources – a systematic 
review of the published literature and an analysis of the 
unpublished cancer registry data, as shown in Figure 1.
Search strategy for systematic analysis and 
data extraction
A systematic analysis of published literature on public do-
main was carried out using the databases Medline, Embase 
and Global Health. The search used both Medical Subject 
Headings (MeSH) and keywords as well as the individual 
countries in Sub–Saharan Africa. Search terms for Medline 
are outlined in Table 1 and were modified where necessary 
for the other databases. Final searches were completed on 
13 January 2012. All references found in the initial search-
es were exported to Refworks.
eracy are reached [2]. The increasing prevalence of NCD is 
also having serious economic impact on health systems 
around the world, with the cost of long–term treatment for 
chronic conditions unsustainable in many health systems 
[3]. NCDs are heavily involved in the vicious cycle of health 
and poverty, where poor health results in loss of income, 
which in turn results in inability to pay for health care or 
maintain a healthy lifestyle [4]. Many NCDs result in 
chronic conditions requiring long–term medical expendi-
tures and ongoing loss of income owing to ill health [5].
Low– and middle–income countries (LMICs) carry the ma-
jority of the burden of NCDs both in terms of incidence and 
mortality [6]. The rates of cancer are dramatically increas-
ing partly because of the ageing population, and partly due 
to the rapid ‘globalisation’ and the adoption of the associ-
ated risk factors within these populations [7]. These risk 
factors include physical inactivity, smoking and alcohol con-
sumption and poor nutrition [8]. A recent study found that 
over half of people aged 50 or over in SSA possessed at least 
2 of the risk factors associated with NCDs [7].
Cancer registries cover less than 25% of the world’s popu-
lation. It is estimated that this proportion would reduce to 
11% if only data of good quality is included [8]. The WHO 
collects data on cancer deaths from cancer registries around 
the world (Box 1) and produces estimates of the global and 
regional burden of cancer [14]. The International Agency 
for Research on Cancer (IARC) also publishes sets of esti-
mates of global incidence and mortality through the GLO-
BOCAN project, the most recent from 2008 [15]. This data 
indicates that colorectal cancer (CRC) is the 5th most com-
mon cancer in SSA [15].
Although the reliability of the information provided in can-
cer registries, especially in SSA, is open to question, the 
registries remain one of the very few sources of data on can-
cer and therefore are the closest we can get to an estimate 
of the burden [8]. The size of the population denominator 
and the accuracy of the data can vary greatly between these 
sources, with only 23 of the 47 SSA countries having a for-
mal registration system for cancer [16]. Many of these reg-
istries only cover small regions, often cities, within a coun-
try. Typically, the few rural registries indicate a much lower 
incidence of cancer than urban registries. Given that the 
majority of accessible data comes from urban registries, 
where only 40% of the population live and with higher risk 
factors, the estimates may be exaggerated [17] or gravely 
under–representative of rural areas.
Although the number of cases of CRC in SSA is thought to 
be very low in comparison to those diagnosed in the West-
ern world (Box 2), it constitutes a significant proportion 
of the cancers in this region [24]. The aims of this study 
were to contribute to improving the evidence on the bur-
den or NCDs in LMICs, by reviewing the evidence from 
Box 1 Non–communicable diseases and the global health agenda
In recent decades the focus of international health organisa-
tions for the developing world has been communicable dis-
eases. As a result huge sums of money and political attention 
have been dedicated specifically to HIV/AIDS, malaria and 
tuberculosis. However, NCD are now a significant barrier to 
reaching some of the Millennium Development Goals 
(MDGs), which focus primarily on reducing infectious dis-
eases [5].
In 2000, the resolution “Prevention and Control on Non–
Communicable Diseases” was adopted by WHO member 
states at the World Health Assembly [9]. This resolution had 
three main aims:
1. Examine the major risk factors associated with NCDs
2.  Introduce health promotion programs aiming to minimise 
the risk factors
3. Improve access to health care
Since this initial commitment to reducing the burden of dis-
ease caused by NCDs the World Health Assembly has also 
endorsed the Global Strategy on Diet and Physical Activity 
and Health [10,11], and the Framework Convention for To-
bacco Control [12].
The UN high–level meeting on non–communicable diseases 
in 2011 recognised four major conditions that had previ-
ously been neglected by the international health community; 
cardiovascular disease, chronic respiratory diseases, diabetes 
and cancer [4,13].
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senting the data from cancer registries across SSA. Further 
review of this paper showed that some of the data had al-
ready been used in published articles found through the 
systematic search. However, there were an additional 21 
data sets that met the criteria for this review. Permission to 
use this further data for analysis in this review was sought 
from the IARC through the World Health Organization 
(WHO). This was granted and is presented in Online Sup-
Box 2 Colorectal cancer and public health
Commonly CRC develops from adenomatous, colonic polyps with 65% in the rectosigmoid and 15% in the 
ascending colon or caecum [18]. Spread of the cancer is typically through the bowel wall and, in cases of rec-
tal carcinoma, may invade the abdominal walls or pelvic viscera. Lymphatic invasion through the systemic or 
portal circulation is common with the liver and lungs as secondary sites [19]. The progression from adenoma 
to carcinoma is a well–documented process involving mutations in a number of genes such as APC (adenoma-
tous polyposis coli), DCC, k–ras and p53 [18,20].
Approximately 80% of CRC is caused by environmental factors such as physical inactivity, smoking, alcohol 
and poor diet [21]. Nutrition is thought to be a major contributing factor to the differences in incidence of CRC 
between developing and developed countries. Western diets, typically high in fibre, increase faecal bulk, re-
ducing transit time and resulting in a higher risk of developing malignancy [21]. The other 10% of CRC is 
caused by genetic mutations in two major pathways resulting in familial adenomatous polyposis (FAP) or he-
reditary non–polyposis colon cancer (HNPCC). Individuals with these diseases have a lifetime risk of CRC of 
up to 80% [21].
Screening for CRC is known to not only help detect the cancer in its early stages, and therefore improve chanc-
es of a curative treatment, but also to detect pre–cancerous lesions which, if removed successfully, can avoid 
more expensive and radical treatments [22]. Colorectal adenomas/polyps are extremely common in the West-
ern world, occurring in approximately 20% of people over the age of 60 [21]. In the UK a national screening 
programmes for CRC have been launched, targeting those in the 50–74 age group. It is estimated that these 
interventions have resulted in a 16% reduction of mortality caused by CRC [23].
The selection criteria used in screening relevant studies 
were: original studies, limited to post–1980, conducted in 
Sub–Saharan Africa as defined by the World Bank [25], in-
volving any age–group or sex, with no restrictions on the 
language of publication. The retained studies were further 
evaluated for quality of design and methods; studies with 
clear case definition of CRC, a population denominator of 
more than 10 000, and numerical measure of disease fre-
quency were included.
Given that the systematic review produced a limited num-
ber of relevant papers, we decided to search for other po-
tential sources of information on CRC in SSA. It was pre-
dicted that many of the cancer registries in SSA might hold 
unpublished or more recent data that could be obtained 
through methods other than systematic review. The IARC 
Web site provided access to an unpublished document pre-
Table 1 Search terms
1 prevalence/ or prevalen*.tw
2 mortality/ or mortal*.tw
3 global burden of disease/ or (disease adj3 burden*).tw
4 incidence/ or inciden*.tw
5 1 or 2 or 3 or 4
6 colorectal adenoma/ or CRC/ or colon cancer/ or rectum cancer/ 
or colorectal carcinoma/ or colorectal disease/
7 (bowel* or large intestine* or large bowel* or gut* or colorect* 
or colo* or rect*) adj3 maligna* or carcinoma* or neoplas* or 
cancer* or tumo* or polyp*).tw
8 6 or 7
9 SSA/ or (Africa* adj3 Sub–Sahara*).tw or (Africa* adj3 south* 
adj3 Sahara*).tw
10 exp Africa or central/ or exp Cameroon/ or exp Central African 
Republic/ or exp Chad/ or exp Congo/ or exp “Democratic Re-
public of the Congo”/ or exp Equatorial Guinea/ or exp Gabon/ 
or exp Africa, Eastern/ or exp Burundi/ or exp Djibouti/ or exp 
Eritrea/ or exp Ethiopia/ or exp Kenya/ or exp Rwanda/ or exp 
Somalia/ or exp Sudan/ or exp Tanzania/ or exp Uganda/ or exp 
Africa, Southern/ or exp Angola/ or exp Botswana/ or exp Leso-
tho/ or exp Malawi/ or exp Mozambique/ or exp Namibia/ or exp 
South Africa/ or exp Swaziland/ or exp Zambia/ or exp Zimba-
bwe/ or exp Africa, Western/ or exp Benin/ or exp Burkina Faso/ 
or exp Cape Verde/ or exp Cote D'Ivoire/ or exp Gambia/ or exp 
Ghana/ or exp Guinea/ or exp Guinea-Bissau/ or exp Liberia/ or 
exp Mali/ or exp Mauritania/ or exp Niger/ or exp Nigeria/ or exp 
Senegal/ or exp Sierra Leone/ or exp Togo/ or exp Comoros/ or 
exp Madagascar/ or exp Mauritius/ or exp Seychelles
11 9 or 10
12 5 and 8 and 11
13 Limit 13 to yr = 1980-current
Figure 1 Sources of data.
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plementary Document, where a sample of the data extract-
ed from this IARC paper is also shown.
Contact details for the directors of cancer registries in SSA 
were provided on the IACR Web site [16]; they were con-
tacted to investigate whether they had any unpublished data 
that could be included with permission. Of the 23 directors 
contacted, 11 replied. Two replies directed attention to the 
IARC document, mentioned above, that had the most recent 
data for their registries. Seven of the replies, although posi-
tive and encouraging, provided no additional data. The re-
ply from Botswana contained data for CRC from 1998 to 
2011. The reply from the South African national cancer reg-
istry provided details of their Web site which had extensive 
information on cases of CRC between 2000 and 2004 and 
population data for 2000–2002. Population estimates for 
2003 and 2004 were obtained through the South African 
government statistics Web site [26]. This second additional 
source provided the current review with a further 21 data-
sets. Examples of the data received directly from cancer reg-
istries are presented in the Online Supplementary Docu-
ment. Owing to the extensive data available for South 
Africa a separate analysis was carried out investigating inci-
dence trends over a 5–year period for different racial groups 
[27-31]. All the unpublished cancer registry data, both from 
the IARC and the IACR, was screened using the same selec-
tion criteria employed in the systematic literature search to 
ensure that the data was of comparable quality.
The initial search of Medline, Embase and Global Health 
databases returned 3127 articles, after the removal of du-
plicates, as shown in Figure 2. Sixty–five articles were 
sourced for the full–text version, and of these, 15 were se-
lected for inclusion in the review. The 50 articles consid-
ered irrelevant did not comply with the exclusion/inclusion 
criteria set for this review; however, some were retained for 
extra information, mainly in the discussion. The 15 rele-
vant articles [10,20,32-42] were then supplemented by the 
21 data sets secured with permission from the IARC [43,44] 
and the further 21 data sets which were received from the 
directors of the cancer registries through the IACR [16]. Six 
articles, which were not suitable for contribution to the es-
timates of incidence but were sourced for full–text copies, 
were retained for information on the biological character-
istics of CRC diagnosed in SSA. Data from the articles was 
extracted and complied into spreadsheets in Microsoft Ex-
cel. Cases of CRC were separated into age groups and by 
sex where appropriate. Incidence estimates were either ex-
tracted from the included data sets or calculated using the 
data reported. All estimates were converted to incidence 
per 100 000 of population (in that sex and age group) per 
year to allow for direct comparison between results. Data 
from 6 additional articles, not used for calculating inci-
dence, were extracted for more detailed information on the 
biological characteristics of CRC.
Case definition used in retained studies
The different definitions of CRC cancer used in the data 
sets are presented in Figure 3. The majority defined it 
based on the current International Classification of Diseas-
es (ICD–10), as devised by the World Health Organisation 
[45]. Five data sets, the ones typically undertaken in the 
1980s and early 1990s, defined CRC based on the earlier 
ICD–9. The remaining data sets (labelled ‘other’ in Figure 
3) took retrospective data from cancer registries and did 
not give a specific definition of CRC. However, 20 of these 
came from the South Africa Cancer Registry and it would 
be reasonable to assume they may have used ICD–10. The 
International Classification of Diseases for Oncology (ICD–
O) was also used in the diagnosis of CRC for nearly 60% 
of the data sets, with five using the 1st edition (ICD–O–1) 
and 28 using the 2nd edition (ICD–O–2).
Figure 2 Search strategy.
Figure 3 Definition of colorectal cancer in data sets. ICD – Inter-
national Classification of Diseases (World Health Organisation).
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Data analysis
There were a total of 57 data sets available from the pub-
lished articles (identified by the systematic review) and the 
unpublished data from the cancer registries. This provided 
a total of 601 datapoints for the calculation of incidence. 
In this pooled series, 28 data sets contained statistics for 
the population of the area covered by the registry separat-
ed by age and sex. They also gave the raw data on the num-
ber of cases of CRC diagnosed over in given time period, 
also separated by age and sex. This allowed for a simple 
calculation of the incidence for each sex and age group. 
Five of the data sets did not contain information on the 
population denominator for each age group. In these cases 
the total population was either cited or could be calculated 
by working back from the reported incidence and cases of 
CRC. This number was then separated into age groups us-
ing total population data for the relevant year and country 
and adjusted to the size of the study population.
In 3 data sets which neither presented the population de-
nominator, nor showed the number of cases of CRC by age 
group, the average age of the population (separated by sex) 
was calculated using UN ESA data for the relevant year and 
country [46]. This was then combined with the overall re-
ported incidence of CRC by sex, calculated using the above 
method. A few data sets presented the number of cases 
separately for colon and rectal cancer. However, data for 
the two were combined to allow for easier comparison with 
other data sets. Tables were compiled using Microsoft Ex-
cel and contained all the information extracted from the 
data sets (see Online Supplementary Document for further 
details).
The average age was calculated as the mean age of each age 
range as reported in the data sets. This resulted in a total 
of 601 data points of incidence against age, separated by 
sex. Graphs containing the 601 data points of incidence by 
age for male, female and both sexes were used to separate 
incidence estimates into age groups. The age ranges were 
based on the groups used by the data sets from the IARC. 
From this, the minimum, maximum, lower quartile, upper 
quartile and median could be calculated for each age group. 
This data was used to create box–and–whiskers plots of the 
collected information. The median values of incidence by 
age group were then combined with the UN ESA statistics 
for the total population of SSA to calculate the number of 
new cases in a year. Examples of this are presented in On-
line Supplementary Document along with the all–age data 
that were calculated by each data set.
Moreover, twenty data sets from the South African cancer 
registry were used to conduct a separate sub–analysis of 
time trends in incidence of CRC in South Africa from 2000 
to 2004. These papers also provided valuable data on the 
relationship between ethnic group and incidence of CRC. 
Furthermore, data from 6 articles excluded from the sys-
tematic review nevertheless had useful background infor-
mation on three aspects of CRC: presenting symptoms, 
anatomical site of tumour and Duke’s Stage of cancer at di-
agnosis. These papers provided percentage distributions, 
from which the averages could be calculated.
To ensure that the data was extracted accurately from both 
the published and unpublished data sets, one author (AG) 
performed a second data extraction on a random selection 
of 8 data sets. The number of cases of CRC as well as the 
underlying population denominator was extracted again. 
This represented 112 of the total 601 data points, and 
found that 100% of the data was the same. Therefore it was 
concluded that the accuracy of the data extraction was 
high.
RESULTS
The data sets showed a wide geographical distribution in 
SSA, as shown in Figure 4. Approximately 5% of data sets 
came from Central Africa, and 15%, 55% and 25% from 
West, Southern and East Africa respectively. However, clus-
ters of data sets came from larger cities or countries known 
to conduct high levels of research. All data sets reported 
cancers from all age groups. The average size of the popu-
lation denominator covered by the cancer registries was 
approximately 2 million. Ninety percent of the data sets 
reported data from population–based cancer registries, the 
remaining six were hospital–based. Some of the national 
cancer registries combined data from regional hospitals and 
smaller registries across the country. Figure 5 shows the 
distribution of active data sets over time. The majority were 
Figure 4 Geographical distribution of data sets. Additional 20 
unpublished data sets came from South African Cancer Registry 
(not shown).
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conducted in the late 1990s to early 2000s with very little 
data available for the 1980s and a limited number from the 
last decade. As a result, any estimates produced by this re-
view should be regarded as referring to 2000.
Incidence of CRC in Sub–Saharan Africa
Figure 6 show the distribution of incidence by age, calcu-
lated from all 57 data sets, producing 601 data points. The 
age–related distribution of incidence shows the predicted 
pattern, based on the biology of CRC, of substantial in-
crease with age. It can also be noted that the calculated in-
cidences are much higher in males than females. There 
were large variations in reported all–age incidence, owing 
to CRC being predominantly a disease of the elderly. As 
such, incidences were separated into age groups that were 
decided based on the ranges used by the primary data 
sources. They were selected to ensure that the majority of 
data points were the median in the ranges chosen. Figure 7 
shows the box–and–whisker plots produced from allocat-
ing the individual data points into age groups. The values 
used for these graphs are presented in Online Supplemen-
tary Document. The median values of incidence for males, 
females and both sexes by age group are shown in Table 2. 
As expected, the incidence increases with age, with the in-
cidence in people below 35 years being negligible. Again, 
it is also evident that the incidence of CRC is significantly 
higher in males than females.
Figure 8 shows the crude incidence of CRC in SSA by Af-
rican sub–regions. The data used for these figures are pre-
sented in Online Supplementary Document. The crude in-
cidence of CRC in SSA was found to be 4.04 cases per 
100 000 population. This incidence was significantly high-
er in Southern Africa, which is discussed later in the text. 
The median incidence values calculated in Table 2 were 
Figure 5 Active data sets active in study years.
Figure 6 Incidence of colorectal cancer by age groups for both 
sexes (A), men (B) and women (C).
Table 2 Crude annual incidence of colorectal cancer in Sub–
Saharan Africa (per 100 000 population)
Age (years)
0–14 15–24 25–34 35–44 45–54 55–64 65–74 75+
Both  
sexes 0.00 0.26 1.15 3.48 8.72 22.11 34.37 86.87
Men 0.00 0.31 1.22 3.40 8.84 21.13 37.00 103.48
Women 0.00 0.10 0.91 2.91 8.09 15.65 23.48 71.36
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shows a comparison of the estimates produced by this re-
view and those from GLOBOCAN [44]. The estimates are 
very similar, with the minor difference perhaps explained 
by the predicted year of the estimates; this will be discussed 
later in this review.
Subsidiary information
Owing to the high standard of data available from the South 
African Cancer Registry for 2000–2004, a separate analysis 
was carried out to assess the relationship between inci-
dence of CRC and ethnicity over time (Figure 9). Although 
the data refers to a relatively short time period, the differ-
ences in incidence between different ethnic groups can be 
observed very clearly. Two of the data sets in this review, 
with further six found through the systematic review, con-
tained information on the nature of the cases of CRC diag-
nosed in SSA. Five papers contained information on the 
Figure 7 Crude incidence of colorectal cancer by age group for 
both sexes (A), men (B) and women (C).
Table 3 Annual number new cases of colorectal cancer in 
Sub–Saharan Africa in 2000
Age (years)
0–1415–24 25–34 35–44 45–54 55–64 65–74 75+
Both sexes 0 456 1428 2791 4651 7808 6732 1099
Men 0 267 762 1371 2294 3514 3321 3069
Women 0 67 565 1158 2216 2922 2492 1575
Figure 8 Annual crude incidence of colorectal cancer by African 
sub–region (per 100000 population).
Table 4 Comparison of estimates of annual new cases of 
colorectal cancer in Sub–Saharan Africa
Current review’s  
estimate
G LOBOCAN 
estimate
Both sexes 23 147 24 711
Men 11 300 13 666
Women 9536 11 045
GLOBOCAN – WHO project to provide contemporary estimates of the 
incidence of, mortality, prevalence and disability-adjusted life years 
(DALYs) from major type of cancers, at national level, for 184 countries 
of the world.
combined with the UN ESA 2000 estimates for SSA. This 
produced Table 3 showing the estimated number of new 
cases of CRC reported in that year. The reason for using the 
2000 population data are considered in the discussion sec-
tion of this review. It is apparent that the majority of diag-
noses of CRC occur in age groups older than 55 years, again 
with CRC more frequent in males than females. Table 4 
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anatomical sub–site of CRC, and the findings are presented 
in Figure 10. Although the percentage of cases in each an-
atomical location varied between the papers, all reported 
the rectum as the most common site, with one paper re-
porting this to include as high as 60% of cases. Data regard-
ing the symptoms at presentation were obtained from five 
papers, shown in Figure 11. The most common present-
ing symptom was found to be bloody stool with nearly 
57% of patients reporting this. It must be remembered that 
some patients may have recognised more than one of the 
symptoms listed. In addition, some patients may not have 
noticed less dramatic symptoms, such as altered bowel 
movements, until prompted by a medical professional. Fig-
ure 12 presents information from four papers that con-
tained data on the Duke’s Stage of the case of CRC diag-
nosed. It can clearly be seen that the majority of cases were 
diagnosed at Stage B, with very few at the first or last stage.
DISCUSSION
This study found the incidence of CRC in SSA to be high-
er in males than females with the peak in the 75+ age group 
and a crude incidence of 4.04 per 100 000 population. On 
the basis of the incidence calculated by this review, it was 
estimated that there were about 23 000 new cases of CRC 
in 2000, with nearly 59% occurring in males. Based on the 
available evidence, the incidence of CRC in SSA appears to 
be much lower than in high–income countries. However, 
the trends associated with sex and age were very similar. 
The male:female ratio in the UK is estimated to be 1.26 
while this review estimated the SSA ratio to be 1.19 [47]. 
One of the greatest concerns related to these overall con-
clusions may be that the incidence of CRC in Africa is sys-
tematically under–reported and that it is generally of poor-
er quality than in high income countries. However, the data 
from South Africa in the years 2000–2004 provide the best 
available evidence that the overall conclusions are likely to 
be true. This is because South Africa has registries of the 
highest qualities and its diverse demographic structure of-
fers a direct comparison of the rates in different ethnic pop-
Figure 9 Crude incidence of colorectal cancer in South Africa 
(per 100 000 population) by ethnicity for 2000–2004.
Figure 10 Colorectal cancer by anatomical tumour site.
Figure 11 Presenting symptoms in colorectal cancer.
Figure 12 Duke's staging of the colorectal cancer.
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ulations. In South Africa, incidence is highest in whites, 
followed by the Asian and then coloured populations, with 
blacks having the lowest reported incidence [27-31].
This review also found that the major anatomical site of 
CRC was the rectum (in 46% of cases), followed by the 
caecum (17%). These trends are fairly similar to those 
found in the Western world. A study looking at anatomical 
sub–site of CRC in Europe found the most common sites 
to be rectum (31%), sigmoid colon (21%) and caecum 
(10%) [48]. Although the presenting symptoms reported 
by papers in this review were not very different from those 
elsewhere in the world, the signs associated with the more 
advanced stages of the disease, such as rectal bleeding, ap-
pear to be more common [49]. Moreover, this review found 
that a majority (57%) of cases of CRC were at Duke’s Stage 
B at diagnosis, with very few cases being found at the most 
treatable Stage A. This does not support concerns that in 
Africa, because of less developed and less efficient health 
systems, cancer would generally be diagnosed at a later 
stage – at least it is not true for CRC and in registries that 
likely over-represent urban areas. However, this may also 
be due to lack of expert knowledge of the condition, lead-
ing to incorrect staging of tumours. This highlights the 
need for further research into this area in order to improve 
public health service provision.
In terms of the quality of primary data used in this study, 
there were two main sources of potential limitation: incom-
plete data and systematic bias. Although the problem of 
incomplete data was only encountered in 9 of the 57 data 
sets, it should not have affected the overall conclusions. 
Twenty–one of those data sets were obtained from direct 
contact with cancer registries in SSA. This review should 
not be affected by a major language bias, as data sets have 
been retrieved in all major languages used in Africa, includ-
ing French and Dutch. It is also unlikely that this review is 
limited by the conventional form of publication bias, as 
unpublished registry data was also included. It is important 
to note that the latter may provide more recent data than 
that from published papers owing to the usual delay in the 
release of articles. The majority of data sets eligible for in-
clusion in this review contained data from the late 1990s 
and early 2000s. As such, any estimates produced by this 
review essentially refer to a mid–point of the year 2000, 
and are based on the correct population denominator from 
UN ESA. This was the best estimate that could be produced 
with the data available However, it is recognised that rates 
of NCDs are increasing in the developing world and there-
fore the estimates for 2000 are likely to be lower than the 
true current level.
This review made a comparison between the estimated 
number of new cases of CRC in Africa and estimates pro-
duced by GLOBOCAN [44]. Although it appears that this 
review underestimates the incidence in comparison to 
GLOBOCAN, it should be noted that there is an 8–year 
difference, with GLOBOCAN reporting the estimates for 
the year 2008. However, a short analysis of the data sourc-
es used by GLOBOCAN found that the majority of their 
data points also came from the 1990s. This probably ex-
plains the great similarity between the two estimates, which 
are very supportive of each other. However, because this 
review uses the same primary data with an additional 36 
data sets it could be viewed as more comprehensive.
Finally, this review used information from 57 mutually ex-
clusive cancer registry data sets, 15 of which came from 
articles published in peer–reviewed journals and 42 from 
unpublished data sources. The assumption is that the peer–
reviewed articles would be of a higher quality so it was im-
portant to explore differentiating incidence across these 
two sources in a simple sensitivity analysis. The results are 
presented in Table 5. Although there are modest differ-
ences in incidence, this is partly driven by the inclusion of 
the South African data sets. The difference in incidence be-
tween published and unpublished data sets was signifi-
cantly lower with the exclusion of South African data from 
both.
In terms of the validity and reliability of case definitions 
used to measure the frequency of CRC in the population in 
Africa, the current National Institute for Clinical Excellence 
(NICE) provides clinical guidelines that recommend the use 
of colonoscopy, biopsy, sigmoidoscopy, CT scan and barium 
enema in the diagnosis of CRC [50]. However, in many re-
source–poor settings, such as those found in a number of 
SSA countries, such extensive diagnostic tests are not fea-
sible. Many registries only document histologically–diag-
nosed cancers, but even this is lacking in some areas [51]. 
This may result in the number of cases of CRC being un-
derestimated in some settings. Another possible point of 
concern comes from the notion that some data sets includ-
ed in this review did not specify whether ICD or another 
classification system was used as their case definition. Ear-
lier versions of the ICD that preceded ICD–10 were recog-
nized to be less specific [52]. This concern should be noted 
in regard to interpreting any fluctuations in the reports from 
cancer registries that were active over a long period of time. 
It is estimated that only 1% of the population of Africa are 
covered by cancer registries [53]. With limited resources 
and critically low numbers of health workers, the imple-
Table 5 Sensitivity analysis of published vs unpublished data sets
Crude incidence of CRC/100 000 
population
Published data 
sets
Unpublished 
data sets
With South Africa 1.11 4.28
Without South Africa 1.07 2.05
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mentation of a cancer registry has not been seen as a prior-
ity in tackling the burden of disease in many countries. 
However, accurate measurement of diseases is vital in 
achieving effective and efficient intervention programs [54].
Although data for 19 different countries in SSA was ob-
tained, over 75% of the data points came from countries in 
Southern and Eastern Africa. These regions were found to 
have the highest incidences of CRC. Given that the major-
ity of these data sets came from South Africa and Zimba-
bwe, it is important to recognise the differences in the pop-
ulation of these countries in comparison to the rest of SSA. 
These two countries had the highest incidence of CRC of 
the countries studied. South African law previously segre-
gated its people into 4 ethnic categories; “Black”, “Co-
loured” (mixed–race), “White” and “Asian/Indian”. Al-
though this law was abolished over 10 years ago, much of 
the population still identify themselves based on these 
groups and many epidemiology studies still separate the 
population in this way [55]. This can still be seen as evi-
dent in the data provided by the South African Cancer Reg-
istry for 2000–2004. Similarly, the data sets from Zimba-
bwe also separate their population into “African” and 
“European”. This separation between ethnic groups allows 
for comparison between the groups, especially given the 
well–documented variation in incidence of CRC between 
white and black populations, which is consistently shown 
to be substantial.
South Africa is also known to have the highest numbers of 
people infected with HIV/AIDS of any country in Sub–Sa-
haran Africa [56]. There is evidence to suggest an increased 
risk of developing CRC amongst HIV/AIDS infected popu-
lations, however the biological mechanism behind this is 
still poorly understood [57]. Karposi’s sarcoma is strongly 
associated with HIV/AIDS infection and there are docu-
mented cases of involvement of the colorectum [58,59]. It 
is also possible that this may account for the higher inci-
dence of CRC in South Africa. However, countries like Swa-
ziland and Botswana, with higher percentages of HIV/AIDS 
infected populations had much lower incidence of CRC.
Ideally, cancer registries should be population–based, how-
ever, in developing countries, this is often not possible. 
Problems such as the limited health system infrastructure 
and cultural and religious obstacles in the reporting of dis-
eases like cancer have contributed to the lack of routine 
data collection [54]. The alternative option of data collec-
tion through a hospital–based registry is better than no reg-
istry at all. This type of data will only cover people who 
have presented and been recognised as symptomatic at a 
local health facility, have been referred to centres where 
there are cancer services, and who can access these health 
care facilities, both physically and financially. However, it 
can still provide valuable information on cancer, particu-
larly if adjustments can be made for selection biases in the 
population using the hospital. Because of this triaging sys-
tem from primary to secondary care, those seeking medical 
attention are likely to be from higher socioeconomic back-
grounds with higher levels of education and a greater 
awareness of the risk factors for developing diseases such 
as cancer. However, these people are also more likely to live 
a ‘Westernised’ lifestyle; increasing their risk of developing 
CRC. Hospital–based studies are also often based in urban 
areas where the risk profile is very different to those people 
living in rural areas. This highlights the need for national, 
population–based studies or more sophisticated data ad-
justments to ensure that any estimates produced are an ac-
curate representation of the whole country.
To illustrate the difference between hospital–based and pop-
ulation–based cancer registries, a comparison of the crude 
incidence of CRC (per 100 000 population) is presented in 
Figure 13. Again, ideally a more sophisticated sub–group 
analysis would be undertaken to account for the influence 
of this apparent difference. Adjustments should be made 
allowing for the differences in the source of the data (pub-
lished/unpublished), geographical coverage (particularly 
with reference to the dominance of South Africa) and the 
ethnic group of patients.
In many urban areas of SSA, there has been an increase in 
health risk behaviours associated with CRC, such as smok-
ing, decreased physical activity, alcohol consumption and 
poor diet. There is also evidence of the increase in the health 
consequences of these behaviours, in terms of increased 
rates of obesity, diabetes and hypertension [51]. It is impor-
tant that health education programs are set up to enable 
people to be more aware of the consequences of these un-
healthy behaviours. Prevention is a more cost–effective and 
Figure 13 Comparison of incidence of colorectal cancer (per 
100 000 population) in sub–Saharan Africa between hospital–
based and population–based cancer registries.
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long–term solution to dealing with the burden of cancer 
than treating the cases once diagnosed [60,61]. Although 
screening for CRC is thought to be cost–effective in high–
income countries, whether this is the case in LMICs is de-
bated. Implementing a screening program for CRC requires 
the purchase and maintenance of expensive equipment, 
skilled specialists and education of the public to maximise 
utilisation. Lambert et al. argue that this is not feasible in 
resource–poor settings like SSA [62]. However, with more 
accurate data from population–based studies it may be that 
the burden of disease attributable to CRC is greater than first 
thought. In this case, screening programmes, particularly if 
they are linked to a more generic family health programme 
engaging both men and women, may be a more cost-effec-
tive option to treating more advanced cancers.
In low–resource countries the national budget devoted to 
health systems is extremely low and as a consequence the 
public health service provision can be very weak [63]. This 
has led to the treatment options for patients with all forms 
of cancer including CRC in SSA being severely limited in 
comparison to patients in the Western world. For instance, 
a surgical procedure commonly performed in high–income 
world as a treatment, such as resection, was noted to only 
be attempted in very few countries that have specialist can-
cer hospitals and only in cases where the patients them-
selves were able to afford the cost of the procedure [24]. 
Cultural factors are also relevant to the acceptance of treat-
ment, with some patients refusing to undergo surgery be-
cause of fear that a colostomy could result in rejection from 
their community [24,49]. It is estimated that only 18% of 
the need for radiation treatment in cancer patients is met 
in Africa as a whole, and this is likely to be even lower in 
the Sub–Saharan region [64]. Delays in seeking medical at-
tention mean that for many patients with advanced stage 
of cancers palliative treatment was the only available op-
tion [49]. Follow–up of patients in all clinical settings is 
notoriously poor. One study reported that less that 30% of 
patients who received adjuvant treatment were seen again 
after six months. Although the reasons for this will be mul-
tifactorial, it was suggested that the treatment for many of 
these patients was unsuccessful and they had died [49].
In order to improve the volume and quality of information 
available on cancer in SSA there needs to be stronger in-
vestment in cancer registries. Being able to counter the ar-
guments that it is not effective, efficient or ethical to invest 
scarce resources in setting–up cancer registries purely for 
epidemiological research purposes is important as such 
data sources will become an invaluable source of evidence 
and guidance for policy setting, programme implementa-
tion and improving practice.
In summary, this systematic analysis has highlighted the 
lack of data on CRC, mirroring the lack of data for all can-
cers in SSA. There is a notable lack of any recent published 
data. Greater use could be made of cancer registry data 
through direct contact and open access to their databases. 
All NCDs, including CRC, are increasing in low–income 
regions such as SSA. It is vital that the burden of disease 
attributable to this is accurately and regularly monitored. 
More information on the dynamics of this burden is also 
required, including who is affected, where and whether 
they have adequate access to treatment.
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